Archive - January 2018
FDA halts trials of Bellicum’s cancer drug
Pfizer pats itself on the back for tax reform lobbying, do-gooder investments
Age bias suit against Biogen claims its North Carolina manufacturing plant favored millennials
The Viagra effect: Sales of Lilly’s ED drug Cialis slide after little blue pill goes generic
Editorial: Rising healthcare costs are a cancer, not a tapeworm
Seattle in $614m move for Cascadian Therapeutics
Cells rockin’ in their DNA
Maternal age over 40 is associated with an increased risk of preterm birth
